MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.
Annals of hematology
View this publicationAnnals of hematology
View this publicationJournal of immunology (Baltimore, Md. : 1950)
View this publicationPublication categories: Top publication
Proceedings of Machine Learning Research
View this publicationInternational journal of molecular sciences
View this publicationAlzheimer's & dementia : the journal of the Alzheimer's Association
View this publicationInternational journal of molecular sciences
View this publicationScience immunology
View this publicationbioRxiv : the preprint server for biology
View this publicationThe Lancet. Neurology
View this publicationJACC. Cardiovascular interventions
View this publication